American Journal of Pharmacy Benefits Launches Website to Expand Resources for Pharmacy Benefit Managers and Formulary Decision Makers
AJPB.com provides daily news and insights on formulary management strategies.
The American Journal of Pharmacy Benefits (AJPB) has officially launched http://www.ajpb.com to provide content from the AJPB print journal, as well as daily news and insights relevant to pharmacy benefit management, including pipeline drug updates, condition and disease treatment research, insurance issues, and more.
“While our print journal is delivered six times a year, we wanted to expand the resources for formulary decision makers by providing a daily news source to help them manage their roles,” said Christopher Hennessy, publisher of AJPB. “With a lack of comprehensive resources available for these executives, the website will feature content from original print articles, which go through rigorous peer review, as well as commentaries, brief reports, editorials and other relevant information for these important decision makers.”
The American Journal of Pharmacy Benefits publishes peer-reviewed research that examines the impact of formulary management strategies on the utilization, cost and quality of pharmacy services. AJPB presents case studies, research, and evidence-based tools to help decision makers develop clinical strategies to manage pharmacy benefits for large populations.
Areas of particular interest include utilization management strategies (i.e., prior authorization, step therapy, generic substitution, etc.), outcomes research on Medicare Part D, formulary development and implementation strategies, research on adherence and compliance, cost- sharing strategies (i.e., copays, coinsurance, consumer-directed health plans, high-deductible health plans, etc.), cost-utility analyses, economic burden of disease, and comparative effectiveness analysis of drug therapies.
About The American Journal of Pharmacy Benefits
Founded in 2009, The American Journal of Pharmacy Benefits is indexed in both EMBASE and Cumulative Index to Nursing and Allied Health Literature, and circulates to approximately 20,000 individuals with important decision-making responsibilities affecting the inclusion and tier placement of drugs on formularies. As the official publication of The Pharmacy & Therapeutics Society, the Journal is also distributed to the Society’s 5,000 members, as well as medical directors, pharmacy directors, corporate benefits managers, and other healthcare professionals across six market segments, including HMO/PPO/IHOs, hospitals, long-term care, pharmacy benefit managers, veteran affairs/government, and employers.